Wellington Management Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,509,348
| Closed | -$267M | – | 2068 |
|
|
2023
Q1 | $267M | Sell |
7,509,348
-2,370,993
| -24% | -$86M | 0.05% | 327 |
|
|
2022
Q4 | $362M | Buy |
9,880,341
+428,133
| +5% | +$16.9M | 0.07% | 263 |
|
|
2022
Q3 | $446M | Buy |
9,452,208
+498,086
| +6% | +$32.2M | 0.09% | 203 |
|
|
2022
Q2 | $642M | Sell |
8,954,122
-476,813
| -5% | -$34.9M | 0.13% | 157 |
|
|
2022
Q1 | $763M | Sell |
9,430,935
-205,075
| -2% | -$17.3M | 0.13% | 164 |
|
|
2021
Q4 | $989M | Sell |
9,636,010
-288,965
| -3% | -$27.7M | 0.16% | 141 |
|
|
2021
Q3 | $868M | Sell |
9,924,975
-851,643
| -8% | -$77.1M | 0.15% | 144 |
|
|
2021
Q2 | $964M | Buy |
10,776,618
+2,779,522
| +35% | +$235M | 0.16% | 133 |
|
|
2021
Q1 | $607M | Buy |
7,997,096
+6,663,775
| +500% | +$502M | 0.11% | 199 |
|
|
2020
Q4 | $90.8M | Buy |
1,333,321
+1,199,797
| +899% | +$74.8M | 0.02% | 618 |
|
|
2020
Q3 | $7.1M | Sell |
133,524
-819,075
| -86% | -$48.8M | ﹤0.01% | 1184 |
|
|
2020
Q2 | $55.5M | Sell |
952,599
-122,069
| -11% | -$6.56M | 0.01% | 676 |
|
|
2020
Q1 | $42.4M | Sell |
1,074,668
-697,325
| -39% | -$40.8M | 0.01% | 681 |
|
|
2019
Q4 | $105M | Sell |
1,771,993
-34,367
| -2% | -$1.85M | 0.02% | 553 |
|
|
2019
Q3 | $96.1M | Sell |
1,806,360
-87,127
| -5% | -$4.47M | 0.02% | 555 |
|
|
2019
Q2 | $96.7M | Sell |
1,893,487
-1,992,685
| -51% | -$92.8M | 0.02% | 569 |
|
|
2019
Q1 | $201M | Sell |
3,886,172
-838,373
| -18% | -$40.6M | 0.05% | 365 |
|
|
2018
Q4 | $186M | Sell |
4,724,545
-135,410
| -3% | -$6.29M | 0.05% | 356 |
|
|
2018
Q3 | $251M | Buy |
4,859,955
+293,339
| +6% | +$14.4M | 0.05% | 334 |
|
|
2018
Q2 | $214M | Buy |
4,566,616
+654,548
| +17% | +$27.1M | 0.05% | 359 |
|
|
2018
Q1 | $139M | Buy |
3,912,068
+2,741,988
| +234% | +$107M | 0.03% | 468 |
|
|
2017
Q4 | $51M | Buy |
1,170,080
+717,299
| +158% | +$33.5M | 0.01% | 766 |
|
|
2017
Q3 | $23.7M | Buy |
452,781
+17,259
| +4% | +$962K | 0.01% | 997 |
|
|
2017
Q2 | $25.5M | Sell |
435,522
-102,200
| -19% | -$5.31M | 0.01% | 951 |
|
|
2017
Q1 | $24.7M | Buy |
537,722
+467,520
| +666% | +$23.3M | 0.01% | 965 |
|
|
2016
Q4 | $3.69M | Sell |
70,202
-847
| -1% | -$41K | ﹤0.01% | 1501 |
|
|
2016
Q3 | $3.17M | Sell |
71,049
-66,392
| -48% | -$2.88M | ﹤0.01% | 1546 |
|
|
2016
Q2 | $5.24M | Buy |
137,441
+14,968
| +12% | +$658K | ﹤0.01% | 1324 |
|
|
2016
Q1 | $5.05M | Buy |
122,473
+15,560
| +15% | +$641K | ﹤0.01% | 1354 |
|
|
2015
Q4 | $5.19M | Buy |
106,913
+97,802
| +1,073% | +$4.35M | ﹤0.01% | 1352 |
|
|
2015
Q3 | $364K | Sell |
9,111
-536
| -6% | -$23.4K | ﹤0.01% | 2028 |
|
|
2015
Q2 | $387K | Buy |
9,647
+740
| +8% | +$25.5K | ﹤0.01% | 2012 |
|
|
2015
Q1 | $292K | Buy |
+8,907
| New | +$246K | ﹤0.01% | 2081 |
|
Other funds holding SYNH
UOC
EIM
HI
FCM
GCL
Wellington Management Group's SYNH Position: Q2 2023 in Review
Wellington Management Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 7,509,348 shares — an estimated $267M sold.
Wellington Management Group first reported a position in SYNH in Q1 2015 and held it in 33 quarters. The position peaked at $989M in Q4 2021. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.
- Wellington Management Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
- Wellington Management Group sold 7,509,348 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $267M.
- Wellington Management Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 33 quarters.
- Wellington Management Group's Syneos Health, Inc. Class A Common Stock position peaked at $989M in Q4 2021.
- 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.